U.S. Neurotherapeutics Markets

Frost & Sullivan, November 1997

Landmark discoveries in the neurosciences are revolutionizing our understanding of the human brain and its chemical structure. This report from Frost & Sullivan covers new drugs designed to treat such diverse brain disorders as multiple sclerosis, ALS, Alzheimer s dementia, and stroke, as well as treatments for more mature markets. Competitive strategies, such as rereleasing new formulations of existing products, are discussed at length. And profiles for companies like Glaxo-Wellcome, Warner-Lambert, and Parke-Davis are included.

- Executive Summary

- The Richest Pipeline in the Industry

- Summary of Major Findings

- Conclusions

- Industry Challenges and Research Methodology

- Challenges Facing the Pharmaceutical Industry

- Time Frame Analysis of Industry Challenges

Customers who bought this item also bought

• The Neurotechnology Industry 2012 Report
• Stem Cell Approaches in Neurology and Psychiatry: 25 Trend Setters for 2013 - 3rd Biennial Report
• The Neurodevice 2012 Report: Neuroprosthetics, Neuromodulation, Neurosurgery, Neurovascular Intervention and Neurosoftware
• Inhaled CNS Therapeutics - Markets & Opportunities
• Lou Gehrigs Disease - Global Strategic Business Report
• Nitric Oxide - Therapeutics, Markets and Companies
• Emerging Medical Technologies Spotlight
• The Handbook of Alzheimer's Disease and Other Dementias. Blackwell Handbooks of Behavioral Neuroscience
• Dealmaking and Industry Outlook: Neurological Disease
• Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019